Janney Montgomery Scott’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $661K | Buy |
13,585
+2,882
| +27% | +$140K | ﹤0.01% | 1838 |
|
|
2025
Q1 | $364K | Buy |
10,703
+3,827
| +56% | +$130K | ﹤0.01% | 2193 |
|
|
2024
Q4 | $271K | Sell |
6,876
-966
| -12% | -$38.1K | ﹤0.01% | 2367 |
|
|
2024
Q3 | $368K | Sell |
7,842
-2,771
| -26% | -$130K | ﹤0.01% | 2165 |
|
|
2024
Q2 | $573K | Buy |
10,613
+1,631
| +18% | +$88.1K | ﹤0.01% | 1787 |
|
|
2024
Q1 | $612K | Sell |
8,982
-281
| -3% | -$19.1K | ﹤0.01% | 1828 |
|
|
2023
Q4 | $580K | Sell |
9,263
-3,824
| -29% | -$239K | ﹤0.01% | 1785 |
|
|
2023
Q3 | $594K | Buy |
13,087
+5,964
| +84% | +$271K | ﹤0.01% | 1651 |
|
|
2023
Q2 | $400K | Buy |
7,123
+1,927
| +37% | +$108K | ﹤0.01% | 2034 |
|
|
2023
Q1 | $235K | Buy |
+5,196
| New | +$235K | ﹤0.01% | 2196 |
|
|
2022
Q4 | – | Sell |
-10,677
| Closed | -$698K | – | 2581 |
|
|
2022
Q3 | $698K | Buy |
10,677
+48
| +0.5% | +$3.14K | ﹤0.01% | 1488 |
|
|
2022
Q2 | $673K | Buy |
10,629
+511
| +5% | +$32.4K | ﹤0.01% | 1443 |
|
|
2022
Q1 | $635K | Sell |
10,118
-230
| -2% | -$14.4K | ﹤0.01% | 1496 |
|
|
2021
Q4 | $784K | Sell |
10,348
-6,914
| -40% | -$524K | ﹤0.01% | 1470 |
|
|
2021
Q3 | $1.93M | Buy |
17,262
+2,519
| +17% | +$282K | 0.01% | 969 |
|
|
2021
Q2 | $2.39M | Buy |
14,743
+1,118
| +8% | +$181K | 0.01% | 869 |
|
|
2021
Q1 | $1.66M | Buy |
13,625
+6,732
| +98% | +$820K | 0.01% | 971 |
|
|
2020
Q4 | $1.06M | Sell |
6,893
-155
| -2% | -$23.7K | 0.01% | 1152 |
|
|
2020
Q3 | $589K | Buy |
7,048
+1,203
| +21% | +$101K | ﹤0.01% | 1354 |
|
|
2020
Q2 | $430K | Buy |
5,845
+541
| +10% | +$39.8K | ﹤0.01% | 1439 |
|
|
2020
Q1 | $225K | Sell |
5,304
-3,552
| -40% | -$151K | ﹤0.01% | 1625 |
|
|
2019
Q4 | $539K | Buy |
8,856
+3,866
| +77% | +$235K | ﹤0.01% | 1389 |
|
|
2019
Q3 | $205K | Buy |
+4,990
| New | +$205K | ﹤0.01% | 1886 |
|